Madrid, Feb 2-4, 2012

Similar documents
Where we stand in EFORT

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

Smokefree Policies in Europe: Are we there yet?

FORUM FOR AEROSPACE NDT BOARDS

European Collaboration on Dementia. Luxembourg, 13 December 2006

Europa Donna in Europe and in Slovenia

EPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS

LEBANON. WCPT COUNTRY PROFILE December 2018

DENMARK. WCPT COUNTRY PROFILE December 2018

Overview of drug-induced deaths in Europe - What does the data tell us?

Real Life, Real PD Survey

GERMANY. WCPT COUNTRY PROFILE December 2018

We are here for our fellow patients

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

Cross Border Genetic Testing for Rare Diseases

WCPT COUNTRY PROFILE December 2017 SERBIA

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

Overview of European Consumption Databases

HPV, Cancer and the Vaccination Programme

The Spanish Society of Medical Oncology: objectives, structure and history

Underage drinking in Europe

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

European Community Pharmacy: a reference in Public Health

Monthly measles and rubella monitoring report

2nd efsli Deaf Interpreters working seminar Ljubljana, Slovenia, 12th Sept 2013

European Patients Academy on Therapeutic Innovation

Allied Health: Sustainable Integrated Health Care for all Australians

Summary of Results for Laypersons

World Connections Committee (WCC) Report

COMMISSION OF THE EUROPEAN COMMUNITIES

Palliative nursing care of children and young people across Europe

Type 1 Diabetes Australian Research Impact Analysis

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

The Federation of European Scleroderma Associations just held a stand at the EULAR Congress in Copenhagen.

Rare Disease Day 2011

Q1 What age are you?

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

real-time AQ data 2007 and plans for 2008

The Identification of Food Safety Priorities using the Delphi Technique

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

Engagement in language assessment / Regions of Europe

Prof. Dr. Gabor Ternak

Germany (DGMM) Total: 5064

ICMART. International Council of Medical Acupuncture and Related Techniques

Highlighting in the WHO European Region:

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

Rheumatoid Arthritis Disease Burden and Access to Treatment

Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

Clinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin

NORDIC CONFERENCE ON RARE DISEASES

European status report on alcohol and health Leadership, awareness and commitment

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

Behavioural indicators in men who have sex with men

EUDY CHILDREN CAMP 2017 FIRST ANNONUCEMENT

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Joint Programming in Neurodegenerative Disease Research (JPND)

Open Access & research metrics Establishing reliable baselines for science policy

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Homeopathy and Anthroposophic Medicine THEIR PLACE IN EUROPEAN HEALTH CARE

Where do EU Contries set the limit for low risk drinking.

COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS

European Society for Phenylketonuria (ESPKU) and Allied Disorders treated as Phenylketonuria. Annual Report Translate visions into reality

MEDICINES SHORTAGES PGEU GPUE. John Chave - Secretary general. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

Pfizer Support to European and International Patient Organisations in 2008

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Alcohol-related harm in Europe and the WHO policy response

The health economic landscape of cancer in Europe

Movember Netherlands. Policy Plan

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

CHRODIS Kick-off. Communication and Dissemination. Cristina Chiotan / Anna Gallinat Public Health Coordinator / Communications Assistant

Hearing Loss: The Statistics

STRATEGIC APPROACH & WORKPLAN 2007

Global Patient Survey. Country-Specific Report Belgium

IBV HOW TO DEAL WITH TODAY S MOST RELEVANT FIELD STRAINS WITHIN THE EUAFME REGION?

Post-test of the advertising campaign Help

Sign Language Act in Europe and Hungary by dr. Ádám Kósa

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

GLP in the European Union Ecolabel detergents, GLP and accreditation

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Measles and rubella monitoring January 2015

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

CLL Patient Voices Survey Final Report. PHEM/DAT/0418/0008 May 2018

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

European Network of Quitlines

Transcription:

Madrid, Feb 2-4, 2012

The Role of FESCA aisbl. Our role is to support and link national scleroderma patient organisations to provide the strength found in unity, pooling our resources to share best practices and practical strategies.

FESCA Organisation Founded in 2007, FESCA is open to all national scleroderma patient support organisationsin Europe In Jan 2012, we have 21 member organisationsfrom 16 countries, and two more countries joining up Each country has two votes The number of member organisationsfrom any country may not exceed two The Council is formed by a delegate from each member organisation FESCA is in useful contact with other countries around the world: Friends of FESCA

FESCA aisbl.council Belgium-French Belgium-Dutch Cyprus Denmark France Germany Hungary Ireland Italy-GILS Italy-AILS, APMAR, ASSMAF Netherlands Poland Portugal Spain Switzerland UK-SSc Soc UK-RSA Finland andnorwayplan to join

Board of FESCA Council An elected, volunteer board of officers, drawn from national societies to direct the umbrella group : President : Ann Tyrrell Kennedy (Ireland) Vice-President : Beata Garay-Toth (Hungary) Treasurer : Despo Charalambous-Demetriou (Greece) Secretary: Catherine Van den Bosch (Belgium)

FESCA aisbl. The aim of the Federation is to support people with scleroderma by promoting the advancement of knowledge, research, and information in the field within medical, governmental, and social arenas, and by increasing awareness of the disease among the general public. Article 5, FESCA Constitution

FESCA aisbl. Our Aims We strive to increase awareness of SSc--low in government and the general public, and even in medical professions We share information with new young associations that support those with SSc throughout Europe We work to increase understanding of medical and sociological aspects of the disease by speaking out, and through our website and publications We offer mutual support We increase communication between doctors and sufferers We are a beginning point for hope

Systemic sclerosis (SSc) A rare connective tissue disease its epidemiology and causes are not even known Multi-system, chronic, incurable, and unpredictable Not inherited, racial, infectious, or contagious Affects the musculoskeletal & vascular systems, skin, and internal organs heart, lung, kidneys and the gastrointestinal tract Found predominately in women Huge number of minor symptoms Overload of symptoms even for doctors treating the disease

SUPPORT GROUP Specialists visited by a SSc patient

Scleroderma Has a major impact on: Work potential Financial situation Life-Partnerships Social relationships Confidence in every area of life Can be: Life-threatening, with the highest mortality rate of any of the connective tissue diseases Life-limiting and isolating, turning people into recluses

National groups Support patients on a daily basis Offer counselling Provide info on treatments & side-effects Give help with psychosocial aspects Offer advice on complementary therapies Provide advocacy throughout the medical odyssey Provide help through maze of paperwork

What do we do? Act as a central clearing house for queries and those who don t know where to begin Collect and distribute information on all aspects of SSc Help doctors to understand those they treat Help national societies to understand what is available Foster excellence in research to improve treatment and patient care Encourage participation in research projects and trials Encourage surveys and research projects and provide a patient base for their success

We also: Seek representation in any organisation that might help our members down the line Work with groups such as Eurordis and EULAR to increase the help available to those with SSc Work for parity of treatment and care and drug availability throughout the EU Spread information about treatment breakthroughs in other parts of the world Interconnect put people in touch with each other

Paul Klee, Kettledrummer 1940, 270 (coloured paste on paper on cardboard), 34.6 x 21.2 cm, Zentrum Paul Klee, Bern, June 29 World Scleroderma Day Scleroderma: More Than Skin Deep

World Scleroderma Day 29 th June annual awareness day event Paul Klee memorial Events throughout world in celebration Theme in 2011 So Rare Goal: Improve access to successful treatments & provide equal and consistent care across the globe Goal: Make those with scleroderma feel less isolated

On SSc Awareness Day... In addition to publicity campaigns in all countries, In Spain, a mobile van In Hungary, the first SSc conference In France, two SSc conferences and a TV commercial In Holland, a SSc conference In Ireland, a launch event with the Minister for Health In Denmark, a blitz on libraries and clinics In Cyprus, a conference and a press event...and more

We share our literature Sharing We share our energies

IRSS We combine our strengths